PTEN and pachyonychia congenita: The PTEN/TMPRSS2 assay (Metamark, Cambridge, MA, USA) is designed to predict PC aggressiveness by detecting the presence or absence of the TMPRSS2 fusion gene and PTEN deletion in biopsy samples.